Delivery Order SPE2DB25D3404-SPE2DB25FUPMH
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,515.37 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This competitively awarded, firm fixed-price contract was issued on July 29, 2025, with an ultimate completion date of July 30, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packaging) on July 29, 2025, with an ultimate completion date of July 30, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. This order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,431.30 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This contract, awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $25,897.33. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of July 25, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $97,535.14 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This firm fixed-price contract, awarded on July 31, 2025, with completion targeted for August 1, 2025, represents a non-competitive set-aside delivery order issued under DLA's pharmaceutical procurement framework. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract has a ceiling value of $6,349.14 and carries no set-aside designation. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at...
- The Defense Logistics Agency awarded a $5,084.04 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 5 mg tablets in a 60-count package. This competitively awarded, non-set-aside contract is scheduled for completion by July 25, 2025, with performance to be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a $12,440.50 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This is a firm fixed-price contract with an ultimate completion date of July 24, 2025, and represents a non-set-aside, competitively awarded procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a contract value of $13,165.20. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set for ultimate completion by July 29, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a ceiling value of $54,937.02 and a completion date of July 30, 2025. This non-set-aside competitive award represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUPMHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,904.49 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed-price contract represents a non-competitive set-aside award and will be performed at the contractor's location in Conshohocken, Pennsylvania. The order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $1 billion ceiling through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant presence as a federal medical supplier through its extensive portfolio of competitively awarded contracts with DLA and related federal health agencies. The company's federal procurement activities span a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains supporting military, veteran, and federal healthcare systems. This delivery order for Eliquis, an anticoagulant medication, represents routine pharmaceutical resupply operations under the existing DLA prime vendor agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 7/29/25 |